StageZero Life Sciences Ltd. (OTCMKTS:SZLSF) Short Interest Up 45.5% in January
StageZero Life Sciences Ltd. (OTCMKTS:SZLSF) Short Interest Up 45.5% in January
StageZero Life Sciences Ltd. (OTCMKTS:SZLSF – Get Rating) saw a significant increase in short interest in the month of January. As of January 31st, there was short interest totalling 6,400 shares, an increase of 45.5% from the January 15th total of 4,400 shares. Based on an average daily trading volume, of 4,400 shares, the days-to-cover ratio is currently 1.5 days.
零生命科學有限公司（OTCMKTS：SZLSF-獲取評級）在一月份短期興趣顯著增加。截至 1 月 31 日，總共有 6,400 股短期利息，較 1 月 15 日的 4,400 股股份增加了 45.5%。根據 4,400 股的平均每日交易量計算，日數保障比率目前為 1.5 天。
StageZero Life Sciences Stock Performance
零階段生命科學股票表現
SZLSF stock traded up $0.00 during midday trading on Monday, hitting $0.05. 1,000 shares of the stock traded hands, compared to its average volume of 6,350. The firm has a market cap of $5.60 million, a P/E ratio of -0.76 and a beta of 0.90. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.08 and a quick ratio of 0.04. The stock's fifty day simple moving average is $0.05 and its 200-day simple moving average is $0.06. StageZero Life Sciences has a 1-year low of $0.04 and a 1-year high of $0.20.
星期一中午交易時間上漲 0.00 美元，與其平均成交量 6,350 宗相比，上漲 0.05 美元。該公司的市值為 560 萬美元，市盈率為 -0.76，貝塔值為 0.90。該公司的債務與權益比率為 0.44，流動比率為 0.08，快速比率為 0.04。該股的五十天簡單移動平均線為 0.05 美元，其 200 天的簡單移動平均線為 0.06 美元。零階段生命科學的 1 年低點為 0.04 美元，1 年新高為 0.20 美元。
StageZero Life Sciences Company Profile
零階段生命科學公司簡介
(Get Rating)
(取得評分)
Featured Stories
特色故事
- Get a free copy of the StockNews.com research report on StageZero Life Sciences (SZLSF)
- Should Medtronic's Recent Colibri Patent Controversy Concern You?
- Checkpoint Software Helps Cyber Security Stocks Bottom
- Under Armour Stock, Gap and Crap, Here's Why
- Is Chevron Positioned To Take Energy Sector Leadership?
- What Does the Consumer Price Index Measure?
- 免費獲取有關階段零生命科學研究報告的副本
- 美敦力最近的 Colibri 專利爭議應該關注您嗎？
- 檢查點軟件幫助網絡安全股票底部
- 在裝甲庫存，差距和廢話，這就是為什麼
- 雪佛龍定位採取能源部門的領導地位嗎？
- 消費者價格指數衡量什麼？
Receive News & Ratings for StageZero Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for StageZero Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
接收 StageZero 生命科學日報的新聞和評分 -在下面輸入您的電子郵件地址，以通過 MarketBeat.com 的免費每日電子郵件通訊接收 StageZero 生命科學及相關公司的最新新聞和分析師評級的簡要每日摘要。
譯文內容由第三人軟體翻譯。